Autoantibody to alanyl‐tRNA synthetase in patients with idiopathic pulmonary fibrosis

Background and objectives:  The pathogenesis of IPF is unknown and it is hypothesized that immunological responses are involved. The purpose of this study was to detect autoantibodies in IPF patients and to identify the relevant antigens.

[1]  P. J. Thompson,et al.  Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. , 2015, The American review of respiratory disease.

[2]  W. Barclay,et al.  Clinical usefulness of the single-breath pulmonucy diffusing capacity test. , 2015, The American review of respiratory disease.

[3]  R. Kingston,et al.  Amplification Using CHO Cell Expression Vectors , 2002, Current protocols in molecular biology.

[4]  T. Mimori,et al.  Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. , 1999, Journal of immunology.

[5]  J A Waldron,et al.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.

[6]  K. Kuwano,et al.  Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. , 1997, The European respiratory journal.

[7]  J. Keene.  RNA surfaces as functional mimetics of proteins. , 1996, Chemistry & biology.

[8]  R. Hubbard,et al.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis , 1996, The Lancet.

[9]  A. Woodcock,et al.  Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. , 1995, Thorax.

[10]  T. Noda,et al.  Human alanyl-tRNA synthetase: conservation in evolution of catalytic core and microhelix recognition. , 1995, Biochemistry.

[11]  P. Schimmel,et al.  Wide cross-species aminoacyl-tRNA synthetase replacement in vivo: yeast cytoplasmic alanine enzyme replaced by human polymyositis serum antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Lamb,et al.  Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. , 1994, Thorax.

[13]  W. Black,et al.  The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.

[14]  D. Lamb,et al.  Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. , 1994, Thorax.

[15]  J. Rodríguez-Sánchez,et al.  Autoantibodies to a transfer RNA-associated protein in a murine model of chronic graft versus host disease. , 1994, Journal of immunology.

[16]  K. Ohta,et al.  Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. , 1992, The American review of respiratory disease.

[17]  T. Standiford,et al.  Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. , 1992, The American review of respiratory disease.

[18]  P. Carré,et al.  Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. , 1991, The Journal of clinical investigation.

[19]  G. Jakab.  Sequential virus infections, bacterial superinfections, and fibrogenesis. , 1990, The American review of respiratory disease.

[20]  F. Arnett,et al.  Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). , 1990, The American journal of medicine.

[21]  S. Schabel,et al.  Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. , 1989, The American journal of medicine.

[22]  S. Park,et al.  Evidence for interaction of an aminoacyl transfer RNA synthetase with a region important for the identity of its cognate transfer RNA. , 1988, The Journal of biological chemistry.

[23]  Paul Schimmel,et al.  A simple structural feature is a major determinant of the identity of a transfer RNA , 1988, Nature.

[24]  F. Arnett,et al.  Antibody to threonyl-transfer RNA synthetase in myositis sera. , 1988, Arthritis and rheumatism.

[25]  M. Schwarz,et al.  Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. , 1987, The American review of respiratory disease.

[26]  P. Jeffrey,et al.  POLYMYOSITIS AND MOLECULAR MIMICRY, A MECHANISM OF AUTOIMMUNITY , 1986, The Lancet.

[27]  M. Mathews,et al.  Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis , 1986, The Journal of experimental medicine.

[28]  C. Florentz,et al.  Possible functional role of viral tRNA‐like structures , 1984 .

[29]  F. Arnett,et al.  Multiplicity of antibodies in myositis sera. , 1984, Arthritis and rheumatism.

[30]  M. Mathews,et al.  Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. , 1984, British medical journal.

[31]  A. Schutte,et al.  Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases. , 1984, Clinical and experimental immunology.

[32]  M. Mathews,et al.  Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity , 1983, Nature.

[33]  T. Mimori,et al.  The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. , 1983, Arthritis and rheumatism.

[34]  J. Brentjens,et al.  Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. II. Role of endothelial damage and repair, induction of autologous phase, and kinetics of antibody deposition in Lewis rats. , 1982, Journal of immunology.

[35]  J. Brentjens,et al.  Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. I. The role of increased permeability of the alveolar capillary wall induced by oxygen. , 1981, Journal of immunology.

[36]  V. Ferrans,et al.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy. , 1981, The American journal of medicine.

[37]  P. Ward,et al.  Immune complex injury of the lung. , 1979, The American journal of pathology.

[38]  E. Holborow,et al.  Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. , 1979, Clinical and experimental immunology.

[39]  M. Schwarz,et al.  Immunofluorescent patterns in the idiopathic interstitial pneumonias. , 1978, The Journal of laboratory and clinical medicine.

[40]  A. Theofilopoulos,et al.  Circulating immune complexes in the idiopathic interstitial pneumonias. , 1978, The New England journal of medicine.

[41]  W. Roberts,et al.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. , 1976, Annals of internal medicine.

[42]  P. Haslam,et al.  Antinuclear antibody and lymphocyte responses to nuclear antigens in patients with lung disease , 1975 .

[43]  A. Fraire,et al.  Diffuse interstitial fibrosis of the lung. , 1973, American journal of clinical pathology.

[44]  J. Weeks,et al.  Antibodies in some chronic fibrosing lung diseases , 1971, Clinical allergy.

[45]  M. Warwick,et al.  Antibodies in some chronic fibrosing lung diseases , 1971, Clinical allergy.

[46]  J. Scadding,et al.  Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs) , 1967, Thorax.

[47]  H. Spiera,et al.  SEROLOGIC FACTORS IN IDIOPATHIC DIFFUSE INTERSTITIAL PULMONARY FIBROSIS. , 1965, The American journal of medicine.

[48]  D. Richards,et al.  Pulmonary in-sufficiency I. Physiological classification, clinical methods of analysis, standard values in normal subjects , 1948 .

[49]  V. Padmanabhan,et al.  Evidence for short or ultrashort loop negative feedback of gonadotropin-releasing hormone secretion. , 1995, Neuroendocrinology.

[50]  M. Munakata,et al.  Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? , 1995, Respiration; international review of thoracic diseases.

[51]  J. Schölmerich,et al.  Detection of antibodies in serum of patients with idiopathic pulmonary fibrosis against isolated rat alveolar type II cells. , 1987, Respiration; international review of thoracic diseases.

[52]  L. de Leij,et al.  Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis. , 1987, Clinical and experimental immunology.

[53]  S. Jimenez,et al.  Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. , 1987, The American review of respiratory disease.

[54]  M. Hodson,et al.  Digital vasculitis in patients with cryptogenic fibrosing alveolitis. , 1984, British journal of diseases of the chest.

[55]  H. Sieker,et al.  Pathogenetic mechanisms of interstitial pulmonary fibrosis in patients with serum antinuclear factor. A histologic and clinical correlation. , 1972, The American journal of medicine.